News Search Results

Displaying Results 401-425 of 1918 "COVID-19"

Nov 19, 2025, 10:10 ET Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion Revenue by 2033 - Grand View Research, Inc.

production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates

More news about: Grand View Research, Inc.


Nov 19, 2025, 09:00 ET Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests

point-of-care and home self-testing. Ian Parfrement, Head of Near Patient Care, Roche Diagnostics: "The COVID-19 pandemic underscored the vital role of diagnostics in identifying infection earlier and more precisely to give the best chance of effective treatment.

More news about: Sapphiros


Nov 19, 2025, 09:00 ET Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests

point-of-care and home self-testing. Ian Parfrement, Head of Near Patient Care, Roche Diagnostics: "The COVID-19 pandemic underscored the vital role of diagnostics in identifying infection earlier and more precisely to give the best chance of effective treatment.

More news about: Sapphiros


Nov 19, 2025, 07:30 ET Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known

More news about: SOLIGENIX, INC.


Nov 18, 2025, 23:36 ET Wearable Medical Devices Market Will reach $184.75 billion by 2033 - Strategic Revenue Insights

healthcare and consumer electronics. Another emerging trend is the expansion of remote patient monitoring (RPM). Since the COVID-19 pandemic accelerated telehealth adoption, healthcare providers increasingly rely on wearable devices to track vital signs, medication adherence, and

More news about: Strategic Revenue Insights


Nov 18, 2025, 12:47 ET AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

were rash, upper respiratory tract infections, fatigue, injection site reactions, constipation, diarrhea, cytokine release syndrome (CRS), pneumonia, COVID-19 and fever. The most common Grade 3 to 4 laboratory abnormalities (≥ 10%) were decreased neutrophil count, lymphocyte count, and platelets. CRS occurred

More news about: AbbVie


Nov 18, 2025, 12:16 ET HealthWell Foundation Launches Fund to Assist Americans with Insurance Premium Costs for ACA Marketplace Plans

Foundation provided similar financial support through the COVID-19 Insurance Premium Assistance Payment Fund. Through the fund, HealthWell provided up to $6,000 in financial assistance for workers who had been laid off or furloughed as a result of the COVID-19 health crisis. We were proud to award over 1,500

More news about: HealthWell Foundation


Nov 18, 2025, 10:15 ET Animal Health Industry Poised for Explosive Growth - Forecasts Hit $112.33B by 2030 - Grand View Research

veterinary surgeries & prevalence of chronic diseases in companion animals. The veterinary healthcare sector has experienced many challenges during the COVID-19 pandemic. Veterinarians could still work despite the shutdown. Browse Horizon

More news about: Grand View Research, Inc.


Nov 18, 2025, 09:00 ET Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

nearing commencement of clinical evaluations. The Co-Dx™ PCR Flu A/B, COVID-19, RSV Test Kit is designed for the simultaneous detection and differentiation of influenza A, influenza B, COVID-19, and RSV on the compact Co-Dx PCR Pro instrument. Using reverse-transcriptase PCR, the device

More news about: Co-Diagnostics


Nov 18, 2025, 08:53 ET Dynamics Unveils The Authority™: The World's First All-in-One E-Commerce Platform for Vaulted Collectibles

the pandemic, the Company's security and safety division worked with NIAID biodefense to be the first group in the world to inactivate SARS-CoV-2 (COVID-19) using optical energy.  Since 2012, Dynamics has also developed collectible platforms and technologies that have managed over 500 million collectibles.  

More news about: The Authority™


Nov 18, 2025, 07:30 ET Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula

statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates,

More news about: Else Nutrition Holdings Inc.


Nov 18, 2025, 07:30 ET BTQ's QPerfect Division Launches GPU-Accelerated QLEO with NVIDIA CUDA-Q Compatibility in Partnership with Quobly

conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays

More news about: BTQ Technologies Corp.


Nov 17, 2025, 17:42 ET Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure.  CytoSorb is not yet approved or cleared in the United States. In

More news about: Cytosorbents Corp


Nov 17, 2025, 13:00 ET Prestigious Cabernet Producer Quilceda Creek Raises $335,000 for Cancer Research Institute Through Library Wine Release

family's core value of giving back. In 2020, the winery donated $365,000 to the Restaurant Employee Relief Fund to support hospitality workers during the COVID-19 pandemic with its first-ever library release, and in 2022, contributed $365,000 to World Central Kitchen towards the organization's "Chefs for

More news about: Quilceda Creek


Nov 17, 2025, 11:58 ET EICMA 2025: una edición que bate récords

registrado en los últimos años y reafirma su dimensión internacional. La fortaleza del evento reside en las cifras: desde la edición posterior a la COVID-19 de 2021 hasta la actualidad, el número de visitantes, expositores y espacio de exposición se ha duplicado. Las cifras de

More news about: EICMA


Nov 17, 2025, 07:30 ET NAPCO to Showcase New Products at the International Security Conference & Exposition

trends, and anticipated product performance. These forward-looking statements include, but are not limited to, statements relating to the impact of COVID-19 pandemic; the growth of recurring service revenue and annual run rate; the introduction of new access control and locking products; the opportunities

More news about: NAPCO Security Technologies, Inc.


Nov 17, 2025, 07:30 ET BTQ Technologies Provides Corporate Update Highlighting QSSN, QCIM Commercialization, and QPerfect Integration

conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays

More news about: BTQ Technologies Corp.


Nov 17, 2025, 06:00 ET Loop's declining value fuels record 16.7% jump in median property tax bill for Chicago homeowners

hard hit this year were homeowners in poorer, predominantly Black areas on the city's South and West sides, where home values have soared since the COVID-19 pandemic. Median residential bills in nine community areas went up by more than 50%, with three topping 80%:

More news about: Cook County Treasurer Maria Pappas


Nov 17, 2025, 05:26 ET Corporate Event Services in U.S Market to Reach $57.86 Billion, by 2035 at 6.3% CAGR: Allied Market Research

The demand for hybrid and virtual corporate events has grown significantly in the U.S., particularly following the COVID-19 pandemic. Organizations now recognize that hybrid events, which combine in-person and virtual participation, provide flexibility, cost efficiency,

More news about: Allied Market Research


Nov 17, 2025, 00:01 ET United States Hosts 1.2 Million International Students at Colleges and Universities, Totaling 6% of U.S. Higher Education

years of growth. The number of undergraduate students grew by 4% to 357,231, marking the first significant increase at that academic level since the COVID-19 pandemic. The number of international students on Optional Practical Training (OPT) reached 294,253 students, an increase of 21% from the prior year.

More news about: Institute of International Education


Nov 17, 2025, 00:01 ET United States Hosts 1.2 Million International Students at Colleges and Universities, Totaling 6% of U.S. Higher Education

years of growth. The number of undergraduate students grew by 4% to 357,231, marking the first significant increase at that academic level since the COVID-19 pandemic. The number of international students on Optional Practical Training (OPT) reached 294,253 students, an increase of 21% from the prior year.

More news about: Institute of International Education


Nov 14, 2025, 07:45 ET Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction

statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates,

More news about: Else Nutrition Holdings Inc.


Nov 14, 2025, 03:36 ET Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine

the United States prescribing information and EU Summary of Product Characteristics, with the most common treatment-emergent adverse events being COVID-19 and nasopharyngitis. Lundbeck is working with regulatory authorities in China, South Korea, and Japan to make eptinezumab available

More news about: H. Lundbeck A/S


Nov 13, 2025, 19:33 ET Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call

statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates,

More news about: Else Nutrition Holdings Inc.


Nov 13, 2025, 17:00 ET Contango Announces Record High $25 Million in Income from Operations and Cash Position of $107 Million for the Quarter Ended September 30, 2025

acquisitions; inability of our management team to execute its plans to meet its goals; the extent of disruptions caused by an outbreak of disease, such as the COVID-19 pandemic; and the possibility that government policies may change, political developments may occur or governmental approvals may be delayed or withheld,

More news about: Contango Ore


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.